| P50 | author | Jacek Skarbinski | Q87131332 |
| P2093 | author name string | Susan Scheer | |
| | Christine L Mattson | |
| | Linda Beer | |
| | Alison J Hughes | |
| P2860 | cites work | Prevention of HIV-1 infection with early antiretroviral therapy | Q24634688 |
| | Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators | Q29547281 |
| | Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre. | Q32054792 |
| | Improving the representativeness of behavioral and clinical surveillance for persons with HIV in the United States: the rationale for developing a population-based approach | Q33288271 |
| | Factors associated with discontinuation of antiretroviral therapy in HIV-infected patients with alcohol problems | Q33298743 |
| | The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals | Q33505475 |
| | Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status | Q33827543 |
| | Combined antiretroviral treatment and heterosexual transmission of HIV-1: cross sectional and prospective cohort study. | Q33853635 |
| | Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis | Q33939861 |
| | Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis | Q34067511 |
| | Short-term discontinuation of HAART regimens more common in vulnerable patient populations | Q34085103 |
| | Contrasting reasons for discontinuation of antiretroviral therapy in workplace and public-sector HIV programs in South Africa | Q34539445 |
| | Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users | Q34741365 |
| | Initiation and continuation of newer antiretroviral treatments among medicaid recipients with AIDS. | Q34744562 |
| | Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users | Q34754918 |
| | The PHQ-8 as a measure of current depression in the general population | Q34815528 |
| | Psychological factors, beliefs about medication, and adherence of youth with human immunodeficiency virus in a multisite directly observed therapy pilot study | Q34988573 |
| | Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature | Q35057790 |
| | HIV patients with psychiatric disorders are less likely to discontinue HAART. | Q35545476 |
| | HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy | Q35680189 |
| | A retrospective study of HIV antiretroviral treatment persistence in a commercially insured population in the United States | Q35872422 |
| | A probability sample for monitoring the HIV-infected population in care in the U.S. and in selected states | Q36292660 |
| | Use of and Adherence to Antiretroviral Therapy in a Large U.S. Sample of HIV-infected Adults in Care, 2007-2008. | Q36302253 |
| | Sex differences in antiretroviral therapy-associated intolerance and adverse events | Q36331864 |
| | Psychiatric Risk Factors for HIV Disease Progression: The Role of Inconsistent Patterns of Antiretroviral Therapy Utilization | Q36389710 |
| | A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs | Q36390767 |
| | The role of adherence to antiretroviral therapy in the management of HIV infection | Q36831639 |
| | Food insecurity is associated with incomplete HIV RNA suppression among homeless and marginally housed HIV-infected individuals in San Francisco | Q37024538 |
| | HIV stigma and missed medications in HIV-positive people in five African countries | Q37276258 |
| | Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. | Q37439827 |
| | Gender differences in discontinuation of antiretroviral treatment regimens. | Q37440855 |
| | Factors and temporal trends associated with highly active antiretroviral therapy discontinuation in the Women's Interagency HIV Study | Q38474793 |
| | Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study | Q39563727 |
| | Food insufficiency and medication adherence among people living with HIV/AIDS in urban and peri-urban settings | Q39984282 |
| | Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease | Q43582240 |
| | Provider barriers to prescribing HAART to medically-eligible HIV-infected drug users | Q43752658 |
| | Discontinuation of potent antiretroviral therapy: predictive value of and impact on CD4 cell counts and HIV RNA levels | Q43955070 |
| | Impact of medical and nonmedical factors on physician decision making for HIV/AIDS antiretroviral treatment | Q44252660 |
| | The relationship of disease severity, health beliefs and medication adherence among HIV patients | Q44878269 |
| | Factors associated with efavirenz discontinuation in a large community-based sample of patients | Q44956373 |
| | Interruption and discontinuation of highly active antiretroviral therapy in the multicenter AIDS cohort study. | Q45285935 |
| | Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus | Q45722048 |
| | HIV-1 transmission after cessation of early antiretroviral therapy among men having sex with men. | Q46107497 |
| | Case management is associated with improved antiretroviral adherence and CD4+ cell counts in homeless and marginally housed individuals with HIV infection. | Q46155992 |
| | Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. | Q46491049 |
| | Vital signs: HIV prevention through care and treatment--United States. | Q46910400 |
| | The influence of psychosocial characteristics and race/ethnicity on the use, duration, and success of antiretroviral therapy. | Q46922962 |
| | Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984-1997. | Q50672426 |
| | Brief questions to identify patients with inadequate health literacy. | Q52087789 |
| | Determinants of HAART discontinuation among injection drug users | Q57259721 |
| | Effect of discontinuing antiretroviral therapy on survival of women initiated on highly active antiretroviral therapy | Q57313893 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | United States of America | Q30 |
| | HIV | Q15787 |
| | anti-retroviral agent | Q50430310 |
| P304 | page(s) | 80-89 | |
| P577 | publication date | 2014-05-01 | |
| P1433 | published in | Journal of Acquired Immune Deficiency Syndromes | Q6294722 |
| P1476 | title | Discontinuation of antiretroviral therapy among adults receiving HIV care in the United States | |
| P478 | volume | 66 | |